Mark S. Shearman

Chief Scientific Officer, Applied Genetic Technologies Corporation.

Companies

Editas MedicineEVP, Chief Scientific Officer Jun 16, 2021 to Feb 15, 2023¹
Applied Genetic Technologies CorporationChief Scientific Officer Jun 2, 2015 to Aug 18, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Editas Medicine EDIT65,559 shares³$154.1K at $2.35Feb 13, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 13, 2023Sold 2,790 shares at $9.67 of Editas Medicine³
Jun 15, 2022Sold 5,145 shares at $10.06 of Editas Medicine⁴
Feb 10, 2022Granted 31,709 shares of Editas Medicine⁵
Dec 22, 2021Granted 9,084 shares of Editas Medicine⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREditas Medicine, EVP, Chief Scientific Officer
2
SEC EDGARApplied Genetic Technologies Corporation, Chief Scientific Officer
3
SEC EDGAREditas Medicine shares after the filing of Feb 13, 2023
4
SEC EDGARForm 4 filed Jun 16, 2022
5
SEC EDGARForm 4 filed Feb 11, 2022
6
SEC EDGARForm 4 filed Dec 23, 2021